Clinical Trials Browser

Phase 1 × LY3023414 × 90 days × Clear all

NCT02057133 2026-01-26

A Study of LY2835219 (Abemaciclib) in Combination With Therapies for Breast Cancer That Has Spread

Phase 1 Active not recruiting

Breast Neoplasms